Cargando…
Combinatorial Pharmacogenetic Interactions of Bucindolol and β(1), α(2C) Adrenergic Receptor Polymorphisms
BACKGROUND: Pharmacogenetics involves complex interactions of gene products affecting pharmacodynamics and pharmacokinetics, but there is little information on the interaction of multiple genetic modifiers of drug response. Bucindolol is a β-blocker/sympatholytic agent whose efficacy is modulated by...
Autores principales: | O'Connor, Christopher M., Fiuzat, Mona, Carson, Peter E., Anand, Inder S., Plehn, Jonathan F., Gottlieb, Stephen S., Silver, Marc A., Lindenfeld, JoAnn, Miller, Alan B., White, Michel, Walsh, Ryan, Nelson, Penny, Medway, Allen, Davis, Gordon, Robertson, Alastair D., Port, J. David, Carr, James, Murphy, Guinevere A., Lazzeroni, Laura C., Abraham, William T., Liggett, Stephen B., Bristow, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468617/ https://www.ncbi.nlm.nih.gov/pubmed/23071495 http://dx.doi.org/10.1371/journal.pone.0044324 |
Ejemplares similares
-
A Personalized BEST: Characterization of Latent Clinical Classes of Nonischemic Heart Failure That Predict Outcomes and Response to Bucindolol
por: Kao, David P., et al.
Publicado: (2012) -
Bucindolol: A Pharmacogenomic Perspective on Its Use in Chronic Heart Failure
por: Smart, Neil A., et al.
Publicado: (2011) -
Crystal Structures of a Stabilized β(1)-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol
por: Warne, Tony, et al.
Publicado: (2012) -
Bucindolol Modulates Cardiac Remodeling by Attenuating Oxidative Stress in H9c2 Cardiac Cells Exposed to Norepinephrine
por: de Lima-Seolin, Bruna Gazzi, et al.
Publicado: (2019) -
An extensive β(1)-adrenergic receptor gene signaling network regulates molecular remodeling in dilated cardiomyopathies
por: Tatman, Philip D., et al.
Publicado: (2023)